Pictet Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$770K Sell
39,470
-2,693
-6% -$53.4K ﹤0.01% 1267
2026
Q1
$811K Buy
42,163
+5,222
+14% +$103K ﹤0.01% 1204
2025
Q4
$700K Buy
36,941
+2,683
+8% +$49.7K ﹤0.01% 1279
2025
Q3
$639K Sell
34,258
-1,247
-4% -$23.3K ﹤0.01% 1263
2025
Q2
$654K Sell
35,505
-18,090
-34% -$321K ﹤0.01% 1240
2025
Q1
$936K Sell
53,595
-22,857
-30% -$385K ﹤0.01% 1090
2024
Q4
$1.32M Buy
76,452
+4,804
+7% +$87.7K ﹤0.01% 981
2024
Q3
$1.33M Buy
71,648
+4,274
+6% +$72.1K ﹤0.01% 947
2024
Q2
$1.04M Buy
67,374
+5,787
+9% +$82.7K ﹤0.01% 986
2024
Q1
$910K Buy
61,587
+2,072
+3% +$28.7K ﹤0.01% 1064
2023
Q4
$849K Buy
59,515
+1,435
+2% +$20.4K ﹤0.01% 1038
2023
Q3
$810K Buy
+58,080
New +$743K ﹤0.01% 1036

Other funds holding SBRA

Pictet Asset Management's SBRA Position: Q2 2026 in Review

Pictet Asset Management reduced its Sabra Healthcare REIT (SBRA) stake by 6.4% in Q2 2026, selling an estimated $53.4K and leaving 39,470 shares worth $770K. The position accounts for ﹤0.01% of the portfolio, ranked #1267.

Pictet Asset Management first reported a position in SBRA in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.33M in Q3 2024. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Pictet Asset Management held 39,470 shares of Sabra Healthcare REIT worth $770K as of Q2 2026.
  • Pictet Asset Management sold 2,693 Sabra Healthcare REIT shares in Q2 2026, an estimated $53.4K.
  • Sabra Healthcare REIT made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1267 holding.
  • Pictet Asset Management first reported a position in Sabra Healthcare REIT in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Sabra Healthcare REIT position peaked at $1.33M in Q3 2024.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.